C-CAMP collaborates with Swiss organisation to tackle resistant bacterial infections

28 December 2022



28 December 2022

The Centre for Cellular and Molecular Platforms (C-CAMP) has joined hands with a Swiss not-for-profit organization, Global Antibiotic Research and Development Partnership (GARDP), to tackle the global problem of resistant bacterial infections.

C-CAMP said that both parties have a joint aspiration to assist in fast-tracking the clinical development, validation and integration of innovative diagnostic solutions for anti-microbial resistance (AMR) into the health system for access by end-users including clinicians, laboratories, and hospitals.

The letter of intent has been signed for the collaboration.


Read the article